Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-05 8:40 pm Purchase | 2025-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 13,509,973 19.700% | 13,509,973![]() (New Position) | Filing History |
| 2026-01-02 4:10 pm Sale | 2025-12-30 | 13D | Zentalis Pharmaceuticals, Inc. ZNTL | Matrix Capital Management Company, LP | 0 0.000% | -6,459,973![]() (Position Closed) | Filing History |
| 2025-12-30 4:10 pm Purchase | 2025-12-18 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | 5AM Opportunities II (GP), LLC | 4,838,571 6.400% | 4,838,571![]() (New Position) | Filing History |
| 2025-12-15 5:16 pm Sale | 2025-12-15 | 13D | Zentalis Pharmaceuticals, Inc. ZNTL | Matrix Capital Management Company, LP | 6,459,973 9.980% | -7,500,000![]() (-53.73%) | Filing History |
| 2025-11-12 4:06 pm Purchase | 2025-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Barclays PLC | 3,841,449 5.320% | 3,841,449![]() (New Position) | Filing History |
| 2025-10-14 4:00 pm Sale | 2025-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Millennium Management LLC | 902,521 1.300% | -2,878,777![]() (-76.13%) | Filing History |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | BlackRock Inc. BLK | 1,613,323 2.200% | -3,071,652![]() (-65.56%) | Filing History |
| 2025-05-14 3:51 pm Unchanged | 2025-03-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Eventide Asset Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-05-13 5:30 pm Sale | 2025-03-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Eventide Asset Management, LLC | 0 0.000% | -4,475,054![]() (Position Closed) | Filing History |
| 2025-02-14 12:13 pm Sale | 2024-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Eventide Asset Management, LLC | 4,475,054 6.280% | -2,615,054![]() (-36.88%) | Filing History |
| 2025-02-04 4:06 pm Purchase | 2025-01-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Millennium Management LLC | 3,781,298 5.300% | 3,781,298![]() (New Position) | Filing History |
| 2025-01-31 12:44 pm Purchase | 2025-01-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 7,050,000 9.900% | 550,000![]() (+8.46%) | Filing History |
| 2025-01-31 10:09 am Sale | 2024-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | The Vanguard Group | 3,271,240 4.590% | -1,341,467![]() (-29.08%) | Filing History |
| 2025-01-22 10:08 am Purchase | 2025-01-21 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 6,500,000 9.100% | 1,500,000![]() (+30.00%) | Filing History |
| 2025-01-08 6:49 pm Purchase | 2025-01-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 5,000,000 7.000% | 1,000,000![]() (+25.00%) | Filing History |
| 2024-12-10 12:42 pm Purchase | 2024-12-03 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Walters William T | 4,000,000 5.600% | 4,000,000![]() (New Position) | Filing History |
| 2024-12-06 11:44 am Sale | 2024-11-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | FMR LLC | 175,863 0.200% | -4,899,974![]() (-96.54%) | Filing History |
| 2024-11-14 4:20 pm Sale | 2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Citadel Advisors LLC | 2,737,221 3.900% | -1,001,261![]() (-26.78%) | Filing History |
| 2024-11-12 6:00 pm Unchanged | 2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | The Vanguard Group | 4,612,707 6.480% | 0 (Unchanged) | Filing History |
| 2024-11-06 2:47 pm Sale | 2024-10-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Eventide Asset Management, LLC | 7,090,108 9.970% | -4,469,867![]() (-38.67%) | Filing History |

